Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/06/2014 | WO2014019991A1 Electrolytic cell, and detection line having said cell and a cell for electrochemically detecting heavy metals |
02/06/2014 | WO2014019943A1 Detection of mixtures in mass-spectrometric microbe identification |
02/06/2014 | WO2014019781A1 Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies |
02/06/2014 | WO2014019727A1 Anti-fcrn antibodies |
02/06/2014 | WO2014019665A1 Method for quantifying the oxidation stability of a fuel |
02/06/2014 | WO2014019644A1 Selective measurement of active human protease coagulation factors |
02/06/2014 | WO2014019520A1 Tumor vessel specific binding polypeptide and application thereof |
02/06/2014 | WO2013173644A3 Immunological markers for adjuvant therapy in melanoma |
02/06/2014 | US20140041064 Compositions and methods for identifying virulence factors and anti-fungal agents |
02/06/2014 | US20140041062 Genetically engineered mouse model for autism spectrum disorder having deletion of shank2 gene and use thereof |
02/06/2014 | US20140039801 Quantised biometric method, apparatus and computer programme |
02/06/2014 | US20140039156 High-throughput screening for compounds modulating expression of cellular macro-molecules |
02/06/2014 | US20140039063 Leukotrienes and asthma exacerbation risk |
02/06/2014 | US20140039033 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
02/06/2014 | US20140039010 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor |
02/06/2014 | US20140038986 Markers associated with human double minute 2 inhibitors |
02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
02/06/2014 | US20140038963 Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction |
02/06/2014 | US20140038944 Furo[3, 2-b] pyrr0l-3-ones as cathespin s inhibitors |
02/06/2014 | US20140038918 Treatments for retinal disorders |
02/06/2014 | US20140038906 Therapeutic and diagnostic methods involving biglycan and utrophin |
02/06/2014 | US20140038901 Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers |
02/06/2014 | US20140038899 Biomarkers for ovarian cancer |
02/06/2014 | US20140038890 Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin |
02/06/2014 | US20140038856 Site-specific labeling of affinity tags in fusion proteins |
02/06/2014 | US20140038852 Use of biomarkers for detecting ovarian cancer |
02/06/2014 | US20140038847 Screening and culturing device and methods for the use thereof |
02/06/2014 | US20140038844 Method, Array and Use for Determining the Presence of Pancreatic Cancer |
02/06/2014 | US20140038841 Biomarkers for osteoarthritis |
02/06/2014 | US20140038839 Human il-17 producing helper t cell detection method |
02/06/2014 | US20140038838 Use of markers in the diagnosis and treatment of prostate cancer |
02/06/2014 | US20140038837 Biomarkers for the detection of early stage ovarian cancer |
02/06/2014 | US20140038834 Novel biomarkers for detecting neuronal loss |
02/06/2014 | US20140038308 Process for producing composite device, and process for bonding device formed of transparent material to adherend |
02/06/2014 | US20140038300 Devices, Systems, and Methods for Aiding in the Detection of a Physiological Abnormality |
02/06/2014 | US20140038299 Microfluidic device and method for fluid clotting time determination |
02/06/2014 | US20140038275 Pharmacology Bioassays for Drug Discovery, Toxicity Evaluation and in vitro Cancer Research Using a 3D Nanocellulose Scaffold and Living Tissue |
02/06/2014 | US20140038271 Methods for cancer detection, diagnosis and prognosis |
02/06/2014 | US20140038231 Isolation and characterization of tumor cells using shear stress measurements |
02/06/2014 | US20140038230 A simple and affordable method for immunophenotyping using a microfluidic chip sample preparation with image cytometry |
02/06/2014 | US20140038223 Crk-a novel target for cancer therapy |
02/06/2014 | US20140038221 Bioengineered human trabecular meshwork for biological applications |
02/06/2014 | US20140038219 Thyroglobulin quantitation by mass spectrometry |
02/06/2014 | US20140038214 Microfluidic flow assay and methods of use |
02/06/2014 | US20140038213 High-molecular-weight adiponectin measurement method |
02/06/2014 | US20140038212 Immunoassay methods |
02/06/2014 | US20140038211 Breast cancer diagnosis using nipple discharge |
02/06/2014 | US20140038210 ANTI-HUMAN IgG1 ANTIBODY |
02/06/2014 | US20140038209 Apparatus and Methodology to Carry Out Biochemical Testing on a Centrifugal Platform Using Flow Splitting Technique |
02/06/2014 | US20140038208 Preparation of anti-peg antibody expressing cell and application thereof |
02/06/2014 | US20140038207 Platelet analysis system |
02/06/2014 | US20140038205 Methods and compositions relating to coagulation assays |
02/06/2014 | US20140038204 Selective measurement of active human protease coagulation factors |
02/06/2014 | US20140038203 Methods for detecting or predicting kidney disease |
02/06/2014 | US20140038186 Alzheimer's disease-specific alterations of protein kinase c epsilon (pkc-epsilon) protein levels |
02/06/2014 | US20140038184 Methods of diagnosing clostridium difficile infection |
02/06/2014 | US20140038183 5-hydroxymethylcytosine in human cancer |
02/06/2014 | US20140038179 Reagent and reagent kit for analysis of immature leukocyte |
02/06/2014 | US20140038177 Brown Fat Cell Compositions and Methods |
02/06/2014 | US20140038169 Quantification of single target molecules in histological samples |
02/06/2014 | US20140038167 Fluid delivery system and method |
02/06/2014 | US20140037805 Local Storage and Conditioning Systems For Nutritional Substances |
02/06/2014 | US20140037757 Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits |
02/06/2014 | US20140037685 Adjuvants that activate adaptive immune system by stimulating nlrp3 |
02/06/2014 | US20140037667 Rapid selection method for hiv gp-120 variants |
02/06/2014 | US20140037666 Compositions for preventing and/or treating an infection by an hiv-1 virus |
02/06/2014 | US20140037665 Pestivirus species |
02/06/2014 | US20140037661 Wheat Antigens and Peptides for Diagnosis of Wheat Induced Hypersensitivity |
02/06/2014 | US20140037659 Snx9 as a novel biomarker for chronic inflammation and associated immunosuppresion and a new regulator of t cell receptor expression and function |
02/06/2014 | US20140037658 Diagnosis and Treatment of Alzheimer's Disease |
02/06/2014 | US20140037655 Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy |
02/06/2014 | US20140037652 Detection and Treatment of Polycystic Kidney Disease |
02/06/2014 | US20140037651 Depleted anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof |
02/06/2014 | US20140037647 Molecular subtyping, prognosis and treatment of prostate cancer |
02/06/2014 | US20140037645 Diagonsis and treatment of autoimmune diseases by targeting autoimmune-related b cells ("abcs") |
02/06/2014 | US20140037644 Prospective Identification and Characterization of Breast Cancer Stem Cells |
02/06/2014 | US20140037642 Methods and compositions relating to inhibition of igf-1r |
02/06/2014 | US20140037635 Methods of treatment using il-17e antagonists |
02/06/2014 | US20140037634 Regulatory t cell mediator proteins and uses thereof |
02/06/2014 | US20140037625 Biomarkers and methods of treatment |
02/06/2014 | US20140037618 Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants |
02/06/2014 | US20140037596 Use of Stem Cells to Reduce Leukocyte Extravasation |
02/06/2014 | US20140037581 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
02/06/2014 | US20140037551 Antibodies to human b7x for treatment of metastatic cancer |
02/06/2014 | US20140036255 Oil in water analyzer |
02/06/2014 | US20140034517 Compositions, Devices, Systems, and Methods for Using a Nanopore |
02/06/2014 | US20140033795 Methods For Diagnosis, Prognosis, Monitoring And Treatment Of Hepatocellular Carcinoma |
02/06/2014 | US20140033794 Method and Device for Diagnosing Electrodes in Sensor Elements |
02/06/2014 | US20140033793 Chromatographic system quality control reference materials |
02/06/2014 | DE19617731B4 Verfahren und Vorrichtung zur Bestimmung der Aktivität von Enzymen und Konzentration von Inhibitoren in Flüssigkeiten Method and apparatus for determining the activity of enzymes and concentration of inhibitors in fluids |
02/06/2014 | DE102012020520A1 Verfahren zur Quantifizierung der Oxidationsstabilität eines Kraftstoffs Method to quantify the oxidation stability of a fuel |
02/06/2014 | DE102012015063A1 Vorrichtung und Verfahren zur Behandlung eines Filtrationsmediums Apparatus and method for treatment of a filtration medium |
02/06/2014 | DE10081888B4 Verfahren zur mehrdimensionalen Analyse eines Proteoms A method for multi-dimensional analysis of the proteome |
02/05/2014 | EP2693216A1 Method for the diagnosis or prediagnosis of a beta-amyloidopathy or an alpha-synucleopathy |
02/05/2014 | EP2693215A1 Blood-glucose level management system |
02/05/2014 | EP2693214A1 Latex particle for measurement reagent, sensitized latex particle, and measurement reagent for immunonephelometry |
02/05/2014 | EP2693213A1 Detection method using immunochromatography capable of determining sample without addition of specimen as operation-failure sample, and test strip for use in same |
02/05/2014 | EP2693191A1 Method for estimating content of fine particles in slurry and process for producing hydrocarbon oil |
02/05/2014 | EP2693186A1 Water absorption test method and water absorption test device for concrete surface |
02/05/2014 | EP2692846A2 Improved fermenter |